Bone Healing Articles & Analysis: Older
18 news found
Several peptides have been shown to support and stimulate the bone healing response and have been proposed as therapeutic vehicles for clinical use. ...
” OSSIOfiber Intelligent Bone Regeneration Technology is a breakthrough in fixation material that provides the first credible solution to the shortcomings of permanent metal hardware, conventional resorbable and allograft implants, and combines unparalleled mechanical strength and natural bone healing in a non-permanent implant. ...
This experiment will examine the biomaterial's osteoconductivity when used in a microgravity environment where bone density and the ability to regenerate new bone tissue is significantly compromised. ...
The clinical use of this product is expected to enhance bone healing, reduce infection rates, and improve the cosmetic outcome of these procedures for patients while eliminating the need for metal fixation hardware. Brain surgery often involves performing a craniotomy, a procedure by which a portion of the skull is temporarily removed using bone ...
Cerapedics Inc., an ortho-biologics company dedicated to enhancing the science of bone repair, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its investigational P-15L Bone Graft for the treatment of degenerative disc disease (DDD). ...
P-15L Bone Graft is based on a small biomimetic peptide (P-15) technology developed by Cerapedics to support bone growth, and is designed to be used as a substitute for autologous bone. In 2015, the company’s first-generation bone graft became the first bone graft to be approved for use in the cervical ...
The data demonstrate that elderly patients in Denmark treated with i-FACTOR bone graft plus local bone had a statistically significantly higher fusion rate compared to allograft plus local bone. ...
BIOSPHERE® FLEX SP EXTREMITIES is a third-generation bioactive glass bone graft solution. Specifically developed to maximize the bone healing potential of bioactive glass. Utilizing the well-known and trusted 45S5 bioactive glass composition that has been proven to be an effective bone graft material. FLEX SP EXTREMITIES is a ...
About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone ...
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the only biologic ...
This agreement will further increase our potential reach across the US market”, said Emil Billbäck, CEO of BONESUPPORT. CERAMENT BONE VOID FILLER is an injectable, moldable and drillable synthetic bone graft substitute designed to help the bone heal in a natural way. CERAMENT resorbs at the same rate that ...
Currently, the standard treatment for chronic osteomyelitis is surgical debridement, long-term, high-dose administration of antibiotics, and – for larger defects – bone grafting which often requires a second surgical procedure to remove the non-resorbable bone graft. CognitOss is intended to offer surgeons a single surgical procedure alternative, ...
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the only biologic ...
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the only biologic ...
The patent, entitled Composition and Methods to Promote Bone Formation, covers the use of methods for stimulating bone growth using the Company’s small molecule, ZetaMet™. ...
This combination of features aim to achieve secure fixation while decreasing overall construct stiffness to limit stress shielding and speed bone healing. To further distinguish our product line from the pack, Avanti Orthopaedics has designed and manufactured bespoke instrumentation, such as the Dynamic Device, to give the surgeon next level tools to facilitate ...
” Cerapedics commercialized i-FACTOR Bone Graft beginning in 2016. The drug-device combination is based on synthetic small peptide (P-15) technology that accelerates new bone formation in patients with degenerative disc disease. ...
The transplanted bone contains stem cells necessary to generate new bone. However, there is a caveat to this approach— as we get older the grafts become less effective because the stem cells in our bones are less efficient at making new bone. The end result is little or no bone healing. ...